Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Fatty heart

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Aug 30, 2022 6:57pm

162 Views

Post# 34931024

RE:RE:Fatty heart

You are welcome, he is one of the three current advisors on the website also both he and his hospital are entitled to milestone payments when and if the NASH trial progresses so he is highly motivated to have that trial started not only financially but also because of all the hard academic work.
https://www.globenewswire.com/news-release/2020/02/04/1979391/0/en/Theratechnologies-Signs-Agreements-With-Massachusetts-General-Hospital-and-Dr-Steven-Grinspoon.html

stephanedodier wrote:
Thanks for sharing Scarlet,

I was wondering where was our friend Dr. Steven K. Grinspoon ...

Seriously, it's been a long time.... is M. Grinspoon still part of the THTX family ?